Cancer 2015: a longitudinal whole-of-system study of genomic cancer medicine
详细信息 查看全文
- 作者：David M. Thomas1 ; d.thomas@garvan.org.au" class="auth_mail" title="E-mail the corresponding author ; Stephen Fox2 ; 4 ; 5 ; Paula K. Lorgelly6 ; David Ashley7 ; Gary Richardson8 ; Lara Lipton9 ; John P. Parisot2 ; 3 ; Mark Lucas10 ; John McNeil10 ; Michael Wright ; for the Cancer 2015 Investigators
- 刊名：Drug Discovery Today
- 出版年：2015
- 出版时间：December 2015
- 年：2015
- 卷：20
- 期：12
- 页码：1429-1432
- 全文大小：360 K
文摘
- •
Cancer is a genetic disease, and genomic advances promise to revolutionise medicine.
- •
The impact on the health system is likely massive, and potentially costly, particularly in publicly funded health systems.
- •
The dominant focus to date is on use of genomic tools to more accurately select patients for molecular therapeutics.
- •
Cancer 2015 is a longitudinal cohort designed to assay the impact of genomic screening on personal and social outcomes for a broad range of cancers in the Australian community.